During the past decade, Research Institute at Nationwide Children's Hospital conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 18 clinical trials were completed, i.e. on average, 90% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 9 clinical trials were completed. i.e. 180% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Institute at Nationwide Children's Hospital" #1 sponsor was "NICHD Neonatal Research Network" with 21 trials, followed by "Nationwide Children's Hospital" with 6 trials sponsored, "Actelion" with 2 trials sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 2 trials sponsored and "Soleno Therapeutics, Inc." with 2 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Institute at Nationwide Children's Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 19 trials as a collaborator, "National Center for Research Resources (NCRR)" with 8 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Ohio State University" with 3 trials as a collaborator and "Canadian Heart Research Centre" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Research Institute at Nationwide Children's Hospital" are "Infant, Newborn" (10 trials), "Infant, Small for Gestational Age" (6 trials), "Infant, Premature" (5 trials), "Infant, Newborn, Diseases" (4 trials) and "Encephalopathy, Hypoxic-Ischemic" (3 trials). Many other conditions were trialed in "Research Institute at Nationwide Children's Hospital" in a lesser frequency.

Most popular intervention types in "Research Institute at Nationwide Children's Hospital" are "Drug" (21 trials), "Other" (8 trials), "Procedure" (7 trials), "Behavioral" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "DCCR" (2 trials), "Hydrocortisone" (2 trials), "Hypothermia" (2 trials) and "Normothermic Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Research Institute at Nationwide Children's Hospital" are 44 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Research Institute at Nationwide Children's Hospital". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 29 completed trials in Research Institute at Nationwide Children's Hospital, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Research Institute at Nationwide Children's Hospital, 5 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".